Etanercept Downregulates the Th17 Pathway and Decreases the IL-17+/IL-10+ Cell Ratio in Patients with Psoriasis Vulgaris

The Role of Etanercept on the Expression of Markers of T Helper 17 Cells and Their Precursors in Skin Lesions of Patients with Psoriasis Vulgaris

(2017) E. Antiga et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Induction of IL-17+ T Cell Trafficking and Development by IFN- : Mechanism and Pathological Relevance in Psoriasis

(2014) I. Kryczek et al.   JOURNAL OF IMMUNOLOGY

Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

(2011) P. Quaglino et al.   DERMATOLOGY

Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses

(2011) Anja Hänsel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis

(2011) Jérôme Biton et al.   JOURNAL OF IMMUNOLOGY

Role of CD4+CD25high+FOXP3+Regulatory T Cells in Psoriasis

(2010) Woo-Jin Yun et al.   Annals of Dermatology

Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis

(2010) L. Diluvio et al.   BRITISH JOURNAL OF DERMATOLOGY

Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy

(2010) S. Coimbra et al.   BRITISH JOURNAL OF DERMATOLOGY

Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy

(2010) Yuan-Hsin Lo et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis

(2010) G. Tonel et al.   JOURNAL OF IMMUNOLOGY

Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis

(2010) Pieter C. M. Res et al.   PLoS One

Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity

(2009) Li Zhang et al.   CLINICAL IMMUNOLOGY

Circulating CD4+CD25brightFOXP3+ T Cells Are Up-Regulated by Biological Therapies and Correlate with the Clinical Response in Psoriasis Patients

(2009) P. Quaglino et al.   DERMATOLOGY

Human Th17 cells: Are they different from murine Th17 cells?

(2009) Francesco Annunziato et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

(2009) Lisa C. Zaba et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

(2009) Shinji Kagami et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Human Th17 cells in infection and autoimmunity

(2009) Federica Sallusto et al.   MICROBES AND INFECTION

Cytokines and anticytokines in psoriasis

(2008) Aldona T. Pietrzak et al.   CLINICA CHIMICA ACTA

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

(2008) M. Caproni et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in Psoriasis vulgaris

(2008) Ling Chen et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells

(2008) Lisa C. Zaba et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY